Hypermarcas (OTCMKTS:HYPMY) Posts Earnings Results

Key Points

• Hypermarcas reported quarterly earnings of $0.12 per share, with a return on equity of 6.19% and a net margin of 11.28%.
• The company announced a dividend of $0.0345, yielding 281.0%, to be paid on January 8th.
• Scotiabank has upgraded Hypermarcas to a "strong-buy" rating, indicating positive analyst sentiment towards the stock.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) announced its earnings results on Wednesday, August 6th. The company reported $0.12 EPS for the quarter, Zacks reports. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Stock Down 5.4%

Hypermarcas stock traded down $0.23 during mid-day trading on Wednesday, hitting $4.07. The company's stock had a trading volume of 975,037 shares, compared to its average volume of 62,765. The firm's 50 day moving average is $4.75 and its 200 day moving average is $4.00. The company has a market cap of $2.58 billion, a PE ratio of 19.39 and a beta of 0.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.26 and a quick ratio of 0.80. Hypermarcas has a 52-week low of $2.64 and a 52-week high of $5.92.

Hypermarcas Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be paid a $0.0345 dividend. This represents a yield of 281.0%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's dividend payout ratio is currently 57.14%.

Wall Street Analysts Forecast Growth

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.